Cepheid Logo
Request Info
Location / Language

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

{{initials}}
Main Menu
Location / Language

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

Request Info
Request Info

Xpert® TV

Order Now
TV virus computer generated depiction.

Fast molecular detection of Trichomonas vaginalis for both women and men

The Need

an ill woman listens to a physician
Trichomoniasis, chlamydia, and gonorrhea are the three most prevalent, treatable STDs in the U.S. If left untreated, complications can include infertility, pelvic inflammatory disease, pregnancy complications, and increased risk of HIV acquisition.1

CDC recommends:1
  • Annual CT/NG screening of all sexually active women under 25
  • Screening of other at-risk individuals including MSM*
  • Testing for chlamydia, gonorrhea, & trichomoniasis using NAATs^ (PCR)
  • Timely testing to support prompt treatment decisions
* MSM — men who have sex with men
^ NAAT — nucleic acid amplification test

The Solution

a male and a female researchers scanning cepheid test cartridges
Accurate on-demand PCR results are ready when you need them
  • On‑demand results can support clinical workflows by providing results during the patient visit
  • The test supports the use of patient‑collected vaginal swab specimens in clinical settings
  • The assay supports multiple validated specimen types

The Impact

a smiling female doctor attends an elderly woman
Provide fast patient results to:
  • Enable test results during the patient visit
  • Support efficient patient care workflows
  • Support timely identification of infection to inform clinical management.
  • Help inform appropriate clinical decision‑making regarding antibiotic use

Connect To Better Outcomes

Request Info

Insights

Get More Insights